Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer
=====================================================================================================================================================================================================================================================

* Abdul Rafeh Naqash
* Justin D McCallen
* Emma Mi
* Sanna Iivanainen
* Mona A Marie
* Daria Gramenitskaya
* James Clark
* Jussi Pekka Koivunen
* Shravanti Macherla
* Sweta Jonnalagadda
* Shanker Polsani
* Rahim Ali Jiwani
* Maida Hafiz
* Mahvish Muzaffar
* Leonardo Brunetti
* Chipman R G Stroud
* Paul R Walker
* Kun Wang
* Youngmin Chung
* Eytan Ruppin
* Se-Hoon Lee
* Li V Yang
* David J Pinato
* Joo Sang Lee
* Alessio Cortellini